Psychiatric Services · 1973 · 18 citations · 7 references
PharmacyPharmacotherapyPsychiatryChemotherapyPsychiatric PharmacotherapyPsychopharmacologyAntipsychotic PharmacotherapyAntipsychotic TherapySchizophrenia PharmacotherapyTreatment DurationTreatment Of Mental DisordersAntipsychotic Medication ManagementAntipsychotic WithdrawalDose TaperingIntermittent Dosing RegimensIntermittent Treatment RegimensMaintenance Antipsychotic TherapyPrescription Drug CostsPsychosis Pharmacotherapy
In an 18-hospital collaborative study, 375 chronic schizophrenics on stable maintenance doses of anti-psychotic drugs were assigned to one of four groups in which medication was withdrawn two or three days a week on varying schedules, or to one in which daily medication was continued. At the end of 16 weeks, there was no significant difference in relapse rate between the continued-treatment and intermittent-treatment groups. That finding suggests that short-term intermittent drug withdrawal is a feasible treatment policy for hospitalized chronic schizophrenics on maintenance chemotherapy. The benefits of a successful intermittent therapy program include less risk of toxicity for the patient; less work for the staff, allowing more time for other therapeutic activities; and lower drug costs for the hospital.
7
Discontinuation or reduction of chemotherapy in chronic schizophrenics
Eugene M. Caffey, Leon S. Diamond, Thomas Frank et al. · Journal of Chronic Diseases · 1964 · 110 citations
Medicine, Pharmacology, Psychiatry +12